Michael J. Mitchell

California Institute for Regenerative Medicine — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

62h-index22.5kcitations245works18.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(95), Advanced biosensing and bioanalysis techniques(38), Nanoparticle-Based Drug Delivery(25), Immunotherapy and Immune Responses(24), CAR-T cell therapy research(23)

Publications244 total

Macrophage cell therapy enabled by interleukin-4 mRNA-loaded lipid nanoparticles to sustain a pro-reparative phenotype in inflammatory injuries
Biomaterials·2025Open Access
Anti-CD38-Targeted Piperazine-Derived Lipid Nanoparticles Overcome Hepatic Clearance for mRNA Delivery to Multiple Myeloma Cells <i>In Vivo</i>
2025Open Access
Dual switches ignite tumour-specific mRNA therapeutics
Nature Nanotechnology·2025
Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics
Bioconjugate Chemistry·2025
Supp Fig S4 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S1 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Drug-loaded bispecific T cell nanoengager overcomes T cell exhaustion for potent cancer immunotherapy
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
Supp Fig S7 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S8 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S6 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025· 1 citedOpen Access
Supp Fig S2 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S3 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S5 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S9 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Data from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Supp Fig S10 from Ubiquitin-Specific Protease 6 mRNA Lipid Nanoparticles Ignite Antitumor Immunity and Suppress Tumorigenesis in Ewing Sarcoma
2025Open Access
Elucidating lipid nanoparticle properties and structure through biophysical analyses
Nature Biotechnology·2025· 6 cited
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
Nanoscale Horizons·2025· 2 citedOpen Access
Author Correction: Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
Nature Communications·2025· 2 citedOpen Access
High-Throughput Formulation Using Fast mRNA Lipid Nanoparticle Assembly via Simple Thermomixing (HTF-FLASH)
Nano Letters·2025· 3 cited
page 1 of 13Next →

Frequent Co-authors

Margaret M. Billingsley(15), Drew Weissman(15), Mohamad‐Gabriel Alameh(13), Xuexiang Han(12), Ningqiang Gong(11), Róbert Langer(9), Kelsey L. Swingle(9), Sarah J. Shepherd(8), Rakan El‐Mayta(8), Michael R. King(7), Lulu Xue(7), Alex G. Hamilton(7), Carl H. June(6), Karin Wang(6), Rachel Riley(5), Marshall S. Padilla(5), Neil C. Sheppard(4), Pedro Pires Goulart Guimarães(4), Alvin J. Mukalel(4), Ajay S. Thatte(4)